"When asked whether an acquisition target had already been identified, the CEO said he could not comment (leaving open the possibility of something in the near term?) but on the size of a potential deal, they said Genzyme would approximate a reasonable benchmark (Sanofi paid $20 billion for Genzyme in 2009)," he wrote. "It is not clear to us whether swapping out one business for another of similar size would lead to much of a net change."
bwaahahahahahaha clearly sny isnt buying mnkd for 20 billion for forget that noise and maybe kev and his sheepy followers are now licking each others wounds because if sny isnt interested in buying out mnkd who else would even bother? sny knows what they would get and they aren't even worth more than a slide in a presentation of future sny growth bwaahahahahahahah sheepy sheeps
You're all right! The management team needs to do something intelligent for a change.
They need to start an advertising blitz to let the world know how great Afrezza is!
I have always wondered how the opening price is derived, especially today with the bad news before the open for SNY. WHO decideds SNY will open at 47.30? I have thought that it was the marketmakers for SNY stock, that they calculate all the buy & sell orders and thru somekind of mathematical equation they reach a price, the Opening price.....my buy order at 49.75 was filled at 47.30 to my surprise.....what a day!!
With a 3.5% dividend, I'll be fine.....I still wrote Nov. 20 calls at 48.00
Anyway, never expected this drop in the stock price. With all the volatitlity in VRX and the drop in BIIB, and the drop in BKD and RHHBY unable to move, it's like stay away from healthcare entirely.....it's either that or pick a possible bottom and establish a position and hope for the best.